IP Library Granted Patent US 10,195,405
Granted Patent B2
US 10,195,405 · App. 15/471,842 · Granted Feb 5, 2019

System and method for treating pulmonary edema

Inventors: Yaacov Nitzan (Hertzelia, IL); Menashe Yacoby (Ramat Gan, IL); Tanhum Feld (Merhavya, IL)
Assignee: White Swell Medical Ltd
A61M27/002A61M1/34A61M1/3639A61M1/3653A61M1/3655A61M1/3659A61M25/0026A61M25/1011A61M2025/0002A61M2025/1015A61M2025/1052A61M2202/0405A61M2205/10A61M2205/3331A61M2205/3334
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,195,405
App. No.
15/471,842
Granted
Feb 5, 2019
Kind
B2
Abstract

Systems, methods, and devices are provided for the treatment of edema. In one aspect a method for implanting an indwelling catheter within a vein of a patient is provided. The catheter can extend from a position upstream of at least one outflow port of a duct of the lymph system to a terminal position downstream of the at least one outflow port. In use, a first restriction can be created within the vein proximal to a distal region of the catheter. The first restriction can define a localized low pressure zone distal of the restriction and within a portion of the vein housing the catheter. The low pressure zone can be adjacent to the at least one outflow port to enable fluid to pass from the at least one lymph duct outflow port into the vein.

Claims (11)

1. A method of treating edema, comprising:

creating a restriction within a vein of a patient, the restriction being created at a single location upstream from an outflow port of a lymph duct and being effective to at least partially restrict blood flow within the vein past the restriction; and

forming a low pressure zone within the vein at a position downstream of the location of the restriction as a result of creating the restriction, the low pressure zone being effective to enhance clearance of lymphatic fluid from the lymph duct.

2. The method of claim 1 , wherein the low pressure zone is adjacent to the outflow port to enable fluid to pass from the outflow port into the vein.

3. The method of claim 1 , wherein the lymph duct is at least one of the thoracic duct and the lymphatic duct.

4. The method of claim 1 , wherein the restriction comprises a selectively expandable balloon formed on an outer wall of a catheter.

5. The method of claim 4 , wherein creating the restriction comprises activating the balloon to move it into an expanded configuration.

6. The method of claim 5 , further comprising monitoring pressure in locations in the patient upstream and downstream of the restriction, and adjusting a degree of expansion of the balloon based on the monitoring of the pressure.

7. The method of claim 1 , further comprising monitoring pressure in at least one location in the patient upstream and/or downstream of the restriction.

8. The method of claim 7 , further comprising adjusting an extent of the restriction based on the monitoring of the pressure.

9. The method of claim 1 , wherein the restriction is created in one of the right and left internal jugular veins.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2018
From: NITZAN, YAACOV; YACOBY, MENASHE; FELD, TANHUM
To: WHITE SWELL MEDICAL LTD
Reel/Frame 044829/0294 →
Continuity (3)
Continuation 14625930 · Feb 19, 2015
Provisional Application 62006206 · Jun 1, 2014
Related Publication 20170197021A1 · Jul 13, 2017
Cited By (10)
US 12,257,425 US 12,318,561 US 12,458,359 US 12,472,334 US 12,502,474 US 12,544,075 US 12,569,654 US 12,605,494 US 12,667,704 US 12,673,180